Skip to main content

The Globe and Mail

3 top stock picks from Goodreid’s Gordon Reid

Gordon Reid is president & CEO of Goodreid Investment Counsel. His focus is on U.S. equities.

Top picks:

Apple Inc.
In an effort to create arguments to support the reasons for a drop in Apple's stock price, some have pointed to fundamental weakness in its operations – a mistake, in Goodreid's opinion. Apple's stock is in a momentum-led down draft that began with U.S. tax selling and has been exacerbated by general selling by shareholders who lack conviction. (Latest purchase: November, 2012 @ $508.)

Story continues below advertisement

United Therapeutics Corp.
A strong portfolio and active pipeline have led to excellent results for this biotech company. However investors are cautious, creating a compelling valuation which has significant upside potential while providing a floor to the stock price. (Latest purchase: December 2012 @ $50.)

Walgreen Co.
Recent events at Walgreen have led investors to be cautious but Goodreid believes that the resolution of the Express Scripts contract, the cost savings and synergies to be achieved with their acquisition of Boots in the U.K. and a strong management team will lead Walgreen's valuation back to its historical level of about 14 times earnings from the current 12 times. (Latest purchase: November 2012 @ $32.)

Past picks:

Google Inc.
Then: $618.07
Now: $720.76
Total return: +16.61 per cent

Oracle Corp.
Then: $29.87
Now: $34.25
Total return: +16.27 per cent

Apple Inc.
Then: $380.19
Now: $527.95
Total return: +40.12 per cent

Total return average: +24.33 per cent

Story continues below advertisement

Market outlook:

The U.S. equity market has quietly worked higher against a backdrop of negative and disconcerting macro developments, a very positive indicator. Interest rates and corporate profits are solidly bullish and if psychology improves to even a neutral position the equity market has significant upside.

Report an error Editorial code of conduct
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to